Detalhe da pesquisa
1.
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
Br J Haematol
; 204(1): 191-205, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38011941
2.
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
Br J Haematol
; 203(2): 244-254, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37584198
3.
Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma.
Haematologica
; 107(5): 1131-1143, 2022 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34162177
4.
Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.
Haematologica
; 107(11): 2685-2697, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35484662
5.
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models.
Haematologica
; 105(11): 2584-2591, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33131247
6.
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Mol Cancer Ther
; 23(3): 368-380, 2024 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38052765
7.
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors.
J Clin Med
; 12(2)2023 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36675328
8.
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms.
bioRxiv
; 2023 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36711490
9.
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma.
EJHaem
; 3(3): 764-774, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36051080
10.
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Blood Adv
; 6(13): 3911-3920, 2022 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35537101
11.
Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α-STAT3 Axis.
Cancer Immunol Res
; 10(12): 1525-1541, 2022 12 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36206577
12.
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors.
Blood Adv
; 5(10): 2467-2480, 2021 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33999145
13.
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
J Exp Clin Cancer Res
; 40(1): 357, 2021 Nov 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34763718
14.
Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors.
RSC Med Chem
; 11(6): 665-675, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33479666
15.
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type.
Cancers (Basel)
; 12(7)2020 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32679859
16.
The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax.
Cancers (Basel)
; 11(6)2019 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31167506
17.
Abrogation of EMILIN1-ß1 integrin interaction promotes experimental colitis and colon carcinogenesis.
Matrix Biol
; 83: 97-115, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31479698
18.
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents.
Clin Cancer Res
; 25(16): 5167-5176, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31182435
19.
The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4ß1 integrin and decreases tumor cell growth.
Oncotarget
; 8(16): 27034-27046, 2017 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28177903